From Off-Label Evidence to Authorised Care: Mapping Europe’s Article 48 Drug Repurposing Pipeline
Open Access
- 30 July 2026
- conference paper
- Published by ScienceOpen
Abstract
No abstract availableFunding Information
- Novo Nordisk Fonden (NNF23SA0087056)